Search for Clinical Trial Results
Meningeal Neoplasms - 13 Studies Found
Status | Study |
Completed |
Study Name: Intrathecal Mafosfamide Condition: Malignant Meningeal Neoplasms Date: 2003-06-17 Interventions: Drug: Intrathecal Mafosfamide |
Completed |
Study Name: Phase I Study of Intrathecal Mafosfamide Condition:
|
Completed |
Study Name: Phase I Study of Intrathecal Topotecan Condition:
|
Completed |
Study Name: Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors Condition: Brain and Central Nervous System Tumors Date: 2002-03-08 Interventions: Drug: mafosfamide |
Terminated |
Study Name: Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System Condition:
|
Terminated |
Study Name: Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma Condition:
|
Recruiting |
Study Name: Concurrent Involved-field Radiotherapy and Intrathecal Chemotherapy for Leptomeningeal Metastases From Solid Tumors Condition: Leptomeningeal Metastasis Date: 2017-03-05 Interventions:
|
Recruiting |
Study Name: Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM) Condition: Leptomeningeal Metastasis Date: 2014-02-21 |
Not yet recruiting |
Study Name: Phase II Study Of Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas Condition: Meningioma Date: 2017-02-22 Interventions: Drug: AZD2014 AZD2014 is a dual mTORC1/mTORC2 inhibitor |
Completed |
Study Name: Mifepristone in Meningioma Condition: Meningioma Date: 2017-01-06 Interventions:
|